Neuland Laboratories Ltd. Stock Analysis NEULANDLAB.NS

Neuland Laboratories Ltd. engages in the manufacture and export of bulk pharmaceutical ingredients and intermediates for the generics industry. The company is focused on manufacture and sale of active pharmaceutical ingredients and allied services. The company supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. The company has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). The company develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. The company develops small molecules and peptides for clinical trials and beyond. The company provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.